4005:TSESumitomo Chemical Co., Ltd. Analysis

National Medical Care Company trades at SAR 130.2, comfortably above its 20‑day SMA (134.24) but below the 50‑day (145.08) and 200‑day (158.67) averages, indicating a short‑term pull‑back within a longer‑term downtrend. The RSI of 42.8 and a bearish trend direction reinforce the momentum weakness, while the MACD histogram (+0.81) and a bullish MACD signal hint at a possible near‑term reversal. The stock sits near the midpoint of its 52‑week range (support SAR 110.8, resistance SAR 162) and faces a high 30‑day volatility of 55.6%, though its beta is very low, suggesting limited correlation with broader market moves. Fundamentally, the company delivers solid earnings (PE 18.3 vs industry 25.2), 8.6% revenue growth, a 19.9% profit margin, and ROE of 18.6% with modest leverage (debt‑to‑equity 23.8%). However, the DCF‑derived fair value of SAR 47.2 is far below the current price, flagging a significant valuation gap despite a sustainable dividend yield of 1.54% and a 28% payout ratio.